U-Neuron Biomedical (ROCO:6973) COGS-to-Revenue : 0.22 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical COGS-to-Revenue?

U-Neuron Biomedical's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$3.27 Mil. Its Revenue for the six months ended in Dec. 2023 was NT$15.02 Mil.

U-Neuron Biomedical's COGS to Revenue for the six months ended in Dec. 2023 was 0.22.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. U-Neuron Biomedical's Gross Margin % for the six months ended in Dec. 2023 was 78.21%.

U-Neuron Biomedical COGS-to-Revenue Historical Data

The historical data trend for U-Neuron Biomedical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical COGS-to-Revenue Chart

U-Neuron Biomedical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

0.16

0.19

0.20

U-Neuron Biomedical Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	-	0.23	0.15	0.18	0.22

U-Neuron Biomedical COGS-to-Revenue Calculation

U-Neuron Biomedical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	5.463	/	27.023
	=	0.20

U-Neuron Biomedical's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.273	/	15.023
	=	0.22

U-Neuron Biomedical (ROCO:6973) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

U-Neuron Biomedical's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3.273 / 15.023
	=	78.21 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

U-Neuron Biomedical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

https://en.u-neuron.com

U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines